Gene · 828
CAPS: calcyphosine
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. CAPS: calcyphosine. Genes, record 828. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/828
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q13938 | Calcyphosin | 275 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents4
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants612
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CAPS papers | Newest fiscal year |
|---|---|---|---|
| P40OD010440 | Caenorhabditis Genetics Center | 5 | 2025 |
| T32MH019836 | Postdoctoral Training Program in Stress and Trauma | 4 | 2025 |
| I50RX003001 | Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS) | 3 | 2025 |
| UL1TR001881 | UCLA Clinical and Translational Science Institute | 3 | 2025 |
| P2CHD050924 | Carolina Population Center | 2 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 2 | 2025 |
| R01GM140127 | An Integrated Biochemical and Structural Approach to Delineating the Biology of EWSR1 | 2 | 2025 |
| T32AA007455 | Psychology Training in Alcohol Research (PTAR) | 2 | 2025 |
| T32AI007019 | Interdisciplinary Immunology Training Program | 2 | 2025 |
| U01DA041156 | 4/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT FIU | 2 | 2025 |
1 to 10 of 612Source NIH's project files
See all 612 nih grantsPapers786
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The evolution of Ca2+-ATPases across plants with profiles in Rhododendron and the function of key members in alleviating high calcium stress. | Hortic Res | 2026 | 42719017 | PubTator, text mining | PubMed |
| The priming factor, CAPS, mediates somatic exocytosis of serotonin. | Neuroscience | 2026 | 42448279 | PubTator, text mining | PubMed |
| Geometry-dependent interfaces shape NLRP3 pyrin domain assembly. | Int J Biol Macromol | 2026 | 42425344 | PubTator, text mining | PubMed |
| Cerebrospinal fluid proteomics identifies calcyphosine and follistatin-like 1 as exploratory candidate proteins of interest in hydrocephalus. | Front Neurol | 2026 | 42293101 | PubTator, text mining | PubMed |
| A DNA damage-activated kinase phosphorylates a transcriptional repressor to control bacterial immune pathway expression. | EMBO J | 2026 | 42265283 | PubTator, text mining | PubMed |
| Mechanisms of disassembly at the actin filament pointed and barbed ends. | Sci Adv | 2026 | 41931606 | PubTator, text mining | PubMed |
| Diverse Scaffolds Facilitate NLRP3 Clustering and Inflammasome Formation in Response to Perturbations in Cell Homeostasis. | Bioessays | 2026 | 41879501 | PubTator, text mining | PubMed |
| Molecular mechanisms of NLRP3 inflammasome activation. | Exp Mol Med | 2026 | 41876821 | PubTator, text mining | PubMed |
| RARRES1 marks an immune-cold, chemoresistance-associated malignant epithelial subpopulation enriched in pancreatic ductal adenocarcinoma. | Cancer Immunol Immunother | 2026 | 41854891 | PubTator, text mining | PubMed |
| Spatial tumor evolution panorama of ovarian cancer. | Cell Rep Med | 2026 | 41850247 | PubTator, text mining | PubMed |
1 to 10 of 786
See all 786 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/828
GET https://conductscience.org/api/genes/v1/828/grants?page=2